Royal Bank of Canada »

Aerovate Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2023-12-31 $79k 3.5k 22.86
2023-09-30 $19k 1.4k 13.57
2023-06-30 $14k 880 15.69
2022-12-31 $46k 1.5k 30.37
2022-09-30 $8.0k 447 17.91